2,400
Participants
Start Date
June 24, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
September 30, 2027
Symptom Monitoring on Renal Replacement Therapy - Hemodialysis (SMaRRT-HD)
Dialysis clinics randomized to the SMaRRT-HD group will use the SMaRRT-HD system to capture patient-reported symptoms and support clinician follow-up. The online system includes the patient symptom ePROM surveys, clinician real-time email alerts, clinician guidances for symptom management, and patient-facing symptom reports as well as an administrative dashboard supporting management of trial participants at clinics using SMaRRT-HD. Designated clinic personnel (i.e., patient care technicians and nurses) will receive training on how to use the system to administer the symptom ePROM surveys to patients on tablet computers. Designated clinic nurses and medical providers will receive training on how to access guidances for symptom management and patient-facing symptom reports in the SMaRRT-HD system. For trial participants in SMaRRT-HD clinics, the SMaRRT-HD system will be implemented in addition to the Usual Care approach to symptom monitoring.
Usual Care
Dialysis clinics randomized to Usual Care will not adopt SMaRRT-HD or any other trial-driven procedures. Usual Care clinics will monitor symptoms through clinical care interactions with participants and by administering a CMS-mandated Health-Related Quality of Life (HRQOL) survey that includes questions about symptoms.
RECRUITING
Fresenius Medical Care, Waltham
Collaborators (1)
University of North Carolina, Chapel Hill
OTHER
Duke University
OTHER
University of New Mexico
OTHER
Fresenius Medical Care North America
INDUSTRY
Patient-Centered Outcomes Research Institute
OTHER
University of Pennsylvania
OTHER